Brief: HBM Holdings Commenced Collaborations On Antibody-Drug Conjugate Projects
30/05/2022 15:02
May 30 (Reuters) - LegoChem Biosciences Inc 141080.KQ :
* COMMENCED COLLABORATIONS ON ANTIBODY-DRUG CONJUGATE
PROJECTS
WITH LEGOCHEM BIOSCIENCES AND DUALITY BIOTHERAPEUTICS
Further company coverage: 141080.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LigaChem Biosciences
See all newsBrief: Ligachem Biosciences To Issue 170 Billion Won Worth Of Convertible Bonds
Brief: Ligachem Biosciences - Issues 2.21 Million New Preferred Shares
Brief: Ligachem Biosciences To Divest 5 Billion Won Worth Of Own Shares
Brief: Ligachem Biosciences To Divest 17 Billion Won Worth Of Own Shares
Brief: Legochem Biosciences To Conduct Capital Increase Of 470 Billion Won For Operational Funds